mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation
β Scribed by Priscila Pereira Costa Araujo; Marjory Alana Marcello; Alfio Jose Tincani; Ana Carolina Trindade Guilhen; Elaine Cristina Morari; Laura Sterian Ward
- Book ID
- 116848113
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 265 KB
- Volume
- 208
- Category
- Article
- ISSN
- 0344-0338
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Numerous studies have investigated the clinical significance of __BRAF__ mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on the usefulness of __BRAF__ mutation as a prognostic marker of PTC. To address this controversy, the freque
## Abstract ## BACKGROUND. __BRAF^V600E^__ mutation and p27^kip1^ expression have been introduced as novel indicators that may predict prognosis in different tumors, as well as in papillary thyroid carcinomas. ## METHODS. Tissue samples from 214 consecutive patients who underwent total or nearβt
## Abstract In papillary thyroid carcinogenesis, the constitutively activated mitogenβactivated protein (MAP) kinase signaling pathway caused by a genetic alteration such as __RET__/__PTC__ rearrangement or mutation of __RAS__ and __BRAF__ genes, is thought to be a major early event. Among these, t